M7824, a novel bifunctional fusion protein concurrently targeting PD-L1 and trapping TGF-β, ameliorated TGF-β1-induced immunosuppression in both in vitro and in vivo models of NSCLC [179]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.